scholarly journals Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards supra-annular valve

2007 ◽  
Vol 134 (3) ◽  
pp. 702-709.e1 ◽  
Author(s):  
Martijn W.A. van Geldorp ◽  
W.R. Eric Jamieson ◽  
A. Pieter Kappetein ◽  
John P.A. Puvimanasinghe ◽  
Marinus J.C. Eijkemans ◽  
...  
Keyword(s):  
Patient Outcome ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Patient Prognosis

scholarly journals Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: Weighing lifetime anticoagulant-related event risk against reoperation risk

2009 ◽  
Vol 137 (4) ◽  
pp. 881-886.e5 ◽  
Author(s):  
Martijn W.A. van Geldorp ◽  
W.R. Eric Jamieson ◽  
A. Pieter Kappetein ◽  
Jian Ye ◽  
Guy J. Fradet ◽  
...  
Keyword(s):  
Patient Outcome ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Related Event ◽  
Biological Prosthesis ◽  
Event Risk

scholarly journals Challenges and opportunities in improving left ventricular remodelling and clinical outcome following surgical and trans-catheter aortic valve replacement

2021 ◽  
Author(s):  
Xu Yu Jin ◽  
Mario Petrou ◽  
Jiang Ting Hu ◽  
Ed D. Nicol ◽  
John R. Pepper
Keyword(s):  
Patient Outcome ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Vascular Function ◽  
Myocardial Strain ◽  
Left Ventricular ◽  
Improve Patient Outcome ◽  
First Choice ◽  
Improve Patient

AbstractOver the last half century, surgical aortic valve replacement (SAVR) has evolved to offer a durable and efficient valve haemodynamically, with low procedural complications that allows favourable remodelling of left ventricular (LV) structure and function. The latter has become more challenging among elderly patients, particularly following trans-catheter aortic valve implantation (TAVI). Precise understanding of myocardial adaptation to pressure and volume overloading and its responses to valve surgery requires comprehensive assessments from aortic valve energy loss, valvular-vascular impedance to myocardial activation, force-velocity relationship, and myocardial strain. LV hypertrophy and myocardial fibrosis remains as the structural and morphological focus in this endeavour. Early intervention in asymptomatic aortic stenosis or regurgitation along with individualised management of hypertension and atrial fibrillation is likely to improve patient outcome. Physiological pacing via the His-Purkinje system for conduction abnormalities, further reduction in para-valvular aortic regurgitation along with therapy of angiotensin receptor blockade will improve patient outcome by facilitating hypertrophy regression, LV coordinate contraction, and global vascular function. TAVI leaflet thromboses require anticoagulation while impaired access to coronary ostia risks future TAVI-in-TAVI or coronary interventions. Until comparable long-term durability and the resolution of TAVI related complications become available, SAVR remains the first choice for lower risk younger patients.

588 Determinants of left ventricular mass regression after aortic valve replacement surgery on aortic stenosis

1999 ◽  
Vol 1 ◽  
pp. S96-S96
Author(s):  
L COELHO ◽  
A SALGADO ◽  
J MALDONADO ◽  
M COSTA ◽  
R PIRES ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Left Ventricular Mass ◽  
Valve Replacement ◽  
Left Ventricular ◽  
Replacement Surgery ◽  
Ventricular Mass ◽  
Valve Replacement Surgery

Red blood cell osmotic fragility after aortic valve replacement

1972 ◽  
Vol 130 (3) ◽  
pp. 327-330
Author(s):  
E. Eyster
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Blood Cell ◽  
Valve Replacement ◽  
Red Blood Cell ◽  
Osmotic Fragility
Sign in / Sign up

Export Citation Format

Share Document